Genmab — November 2016
-
Trump’s brief medicines update sends Trump’s brief medicines update sends tongues wagging at ‘FDA reform’ promise
tongues wagging at ‘FDA reform’ promise -
Det er nu ikke det værste signal at sende til medicinalindustrien.
-
Enig, men som artiklen også siger; "What reform will actually mean remains highly vague."
-
New Multiple Myeloma Drug Can Prove More Beneficial If Administered Earlier http://my.medicarepublic.com/new-multiple-myeloma-drug-can-prove-more-beneficial-if-administered-earlier/
-
God morgen.
-
Genmab gør klar til klinisk stormløb
Det danske biotekselskab Genmab kan ifølge analytikerne få tocifrede milliardindtægter fra Darzalex over de næste fire år, og firmaet vil bruge en del af de pengestrømme til i samme periode at sende en lang række nye lægemiddelkandidater i klinikken. Den første er næsten allerede sendt af sted.
(medwatch.dk)
-
Som forventet ingen reaktion på Jans salg af aktier.
Men hvor er det bare godt for alle.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind